KF Standeven, RAS Ariëns, P Whitaker, AE … - Diabetes, 2002 - Am Diabetes Assoc The antihyperglycemic drug dimethylbiguanide (DMB, also known as metformin)
reduces the risk of cardiovascular complications in type 2 diabetes, although
the mechanism(s) involved are unclear. DMB reduces glycosylation-related ... Cited by 35 - Related articles - BL Direct - All 4 versions
PJ Grant - Thrombosis and haemostasis, 1998 - cat.inist.fr METFORMIN REDUCES CIRCULATING FACTOR VII CONCENTRATIONS IN PATIENTS WITH TYPE
2 DIABETES MELLITUS. PJ GRANT Thrombosis and haemostasis ... Cited by 15 - Related articles - BL Direct - All 2 versions
G Jörneskog, N Egberg, B Fagrell, K Fatah, B … - Diabetologia, 1996 - Springer A high fibrinogen level is an independent risk factor for coronary heart
disease, stroke and peripheral ar- terial disease in the general population [1,
2]. In dia- betic patients, there is a 2–3 fold greater risk of coro- ... Cited by 39 - Related articles - BL Direct - All 3 versions
- ►ahajournals.org JD Mills, RAS Ariens, MW Mansfield, PJ Grant - Circulation, 2002 - Am Heart Assoc Methods and Results— The ex vivo fibrin structure of 100 healthy male
relatives of patients with premature CAD and 100 age-matched control subjects
was assessed by measurement of permeability (K s ), fiber mass-length ratio ... Cited by 53 - Related articles - BL Direct - All 5 versions
S He, M Blomback, G Yoo, R Sinha, AH … - ANNALS-NEW YORK ACADEMY OF SCIENCES, 2001 - interscience.wiley.com Abstract: To assess how treatment with acetylsalicylic acid (ASA) alters the
fibrin network structure, clotting was initiated in purified fibrinogen
incubated with ASA by adding thrombin. Clotting time and maximum absorbance ... Cited by 22 - Related articles - BL Direct - All 4 versions
- ►hematologylibrary.org EJ Dunn, RA Ariens, M de Lange, H Snieder, … - Blood, 2004 - bloodjournal.hematologylibrary.org Coronary artery thrombosis following plaque rupture is an important feature of
myocardial infarction, and studies have highlighted the role of coagulation in
this condition. Although genetic and environmental influences on the ... Cited by 34 - Related articles - BL Direct - All 8 versions
DP Dhall, CH Nair - Journal of diabetes and its complications - ncbi.nlm.nih.gov Fibrin network structure is altered by diabetes, peripheral vascular disease,
and by some drugs. The antidiabetic drug, gliclazide, increases fibrin fiber
thickness but reduces whole network permeability. The networks are, ... Cited by 9 - Related articles - All 2 versions
K Fatah, A Silveira, P Tornvall, F Karpe, M … - Thrombosis and haemostasis, 1996 - cat.inist.fr The native fibrin gel structure formed in vitro from plasma samples was examined
by liquid permeation of hydrated fibrin gel networks in 38 unselected men who
had suffered a myocardial infarction before the age of 45 years and in 88 ... Cited by 108 - Related articles - BL Direct - All 2 versions
G Jorneskog, LO Hansson, NH Wallen, M … - Journal of Thrombosis and Haemostasis, 2003 - interscience.wiley.com Summary. Background: Patients with Type 1 diabetes have a tighter plasma fibrin
gel structure, to which impaired glycemic control might contribute. Improved
glycemic control can be achieved with continuous subcutaneous insulin ... Cited by 14 - Related articles - All 3 versions
MR Hammer, PN John, MD Flynn, AJ … - Annals of clinical biochemistry, 1989 - ncbi.nlm.nih.gov Fibrinogen is a plasma protein with a short half-life of four days and,
therefore, glycated fibrinogen may be valuable as an index of short-term
diabetic control. We have developed a simple, rapid method for determining ... Cited by 15 - Related articles
